Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$2.10 USD
-0.13 (-5.62%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $2.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
JAGX 2.10 -0.13(-5.62%)
Will JAGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for JAGX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for JAGX
12 Health Care Stocks Moving In Monday's Pre-Market Session
Jaguar Health (JAGX) Advances in Canalevia-CA1 Study for Dogs | JAGX Stock News
Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 ...
Jaguar Health initiates enrollment in study of Canalevia-CA1 drug for dogs
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian ...